Bank of New York Mellon Corp - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$110,157
-43.6%
36,719
-53.8%
0.00%
Q2 2023$195,393
-43.7%
79,428
-48.3%
0.00%
Q1 2023$346,917
-46.6%
153,503
-17.5%
0.00%
Q4 2022$649,706
-91.8%
186,162
-13.4%
0.00%
-100.0%
Q3 2022$7,955,000
+73.1%
214,876
-11.2%
0.00%
+100.0%
Q2 2022$4,596,000
-28.2%
242,019
+2.1%
0.00%0.0%
Q1 2022$6,397,000
+33.4%
237,013
+11.3%
0.00%0.0%
Q4 2021$4,796,000
-7.6%
212,862
+7.5%
0.00%0.0%
Q3 2021$5,188,000
-18.6%
197,934
-0.6%
0.00%0.0%
Q2 2021$6,374,000
-4.5%
199,124
+5.1%
0.00%0.0%
Q1 2021$6,674,000
+26.0%
189,544
+14.8%
0.00%0.0%
Q4 2020$5,295,000
-20.7%
165,119
-7.0%
0.00%
-50.0%
Q3 2020$6,677,000
+12.7%
177,499
+34.0%
0.00%0.0%
Q2 2020$5,926,000
+77.0%
132,431
+34.9%
0.00%
+100.0%
Q1 2020$3,348,000
-16.3%
98,144
-4.4%
0.00%0.0%
Q4 2019$4,002,000102,6140.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders